![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Voluntis’ Digital Cancer App is CE Marked
Voluntis’ Digital Cancer App is CE Marked
![Mobile apps client cellphone cell phone](https://www.fdanews.com/ext/resources/test/Device_Images6/Apps-Mobile-Cell-Phone-Cellphone-client.gif?t=1605565808&width=430)
November 17, 2020
Voluntis’ Oleena, a software application that assists in the self-management of cancer symptoms, has received CE mark certification.
The prescription mobile app uses algorithms to provide automated, real-time recommendations and remote monitoring to cancer patients based on a personalized care plan.
The recommendations include advice on dietary adjustments and the use of symptomatic treatments over time, personalized dosing and alerts when escalation of care is needed.
Upcoming Events
-
21Oct